UBS cuts Healthpeak Properties stock target to USD 20.00

Published on 10/17/2026 at 19:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

November 2, 2026 is the reporting date for Healthpeak Properties stock. The quote was USD 18.98 on October 16, 2026, up 0.11 percent versus the prior close.

Analyst target meets reporting calendar

On October 13, 2026, UBS cut its Healthpeak Properties target from USD 21.50 to USD 20.00.
Second-quarter revenue reached USD 771.58 million, 6.33 percent above consensus of USD 725.64 million.
Healthpeak Properties stock was last at USD 18.98 at 4:00 p.m. ET on October 16, 2026, 0.11 percent above the prior close of USD 18.96.
Healthpeak Properties will report third-quarter results on November 2, 2026.

Modernes Ambulanzgebäude von Healthpeak Properties US42226K1051 bei goldenem Abendlicht — Healthpeak Properties US42226K1051 zeigt modernes Ambulanzgebäude mit Glasfassade bei goldenem Abendlicht auf gepflegtem Campus, Illustration mit AI erstellt.

UBS cut its Healthpeak Properties target from USD 21.50 to USD 20.00 on October 13, 2026, while keeping a Neutral rating, according to Markets Insider. The new target is 5.37 percent above the October 16 price of USD 18.98. Healthpeak Properties was last at USD 18.98 on October 16, 2026 at 4:00 p.m. ET on the NYSE, up 0.11 percent versus the prior close of USD 18.96.

Revenue beat the consensus estimate

Healthpeak's second-quarter 2026 revenue reached USD 771.58 million, 2.47 percent above the first-quarter figure of USD 752.95 million. The quarterly revenue also stood 6.33 percent above the USD 725.64 million consensus estimate cited by MarketBeat. The same report placed quarterly earnings per share at USD 0.08 against a USD 0.03 estimate.

Stock sits below its yearly high

The October 16 last quote was USD 18.98, with a 52-week range of USD 15.70 to USD 22.95. The price stood 17.30 percent below the high and 20.89 percent above the low. Trading volume reached 5,638,068 shares, 3.09 percent above the average volume of 5,469,289 shares for the same quote snapshot.

Valuation and reporting date

Healthpeak carried a market capitalization of USD 13.1 billion, a P/E ratio of 54.23 and a trailing dividend yield of 6.00 percent as of October 16, 2026. The company is scheduled to report third-quarter 2026 results after the NYSE close on November 2, 2026, followed by a conference call on November 3, 2026. Healthpeak gave those dates in its October 1 release, available from Healthpeak Properties.

Comparison with peers

DOC (NYSE, USD): plus 0.11 percent, P/E 54.23, market capitalization USD 13.1 billion.

Welltower (NYSE, USD): plus 0.09 percent, P/E 124.26, market capitalization USD 169.2 billion.

Ventas (NYSE, USD): plus 1.18 percent, P/E 159.00, market capitalization USD 44.0 billion.

The next reporting date

Healthpeak's November 2, 2026 release date gives investors the next defined checkpoint for revenue, earnings and operating guidance. The November 3 conference call follows at 10:00 a.m. ET.